Lupin gets Form 483 for Pune's biotech facility
The inspection concluded with the issuance of Form 483 with seventeen observations
Quality / GMP | 21/10/2022 | By Sudeep Soparkar | 648
US FDA issues four observations to Alembic Pharma's Panelav plant in Gujarat
The facility was inspected from October 4 to October 14, 2022
Quality / GMP | 19/10/2022 | By Sudeep Soparkar | 410
US FDA grants tentative approval for Zydus' for Valbenazine and Roflumilast tabs
Both medicines will be produced at the group's formulation manufacturing plant in Ahmedabad Special Economic Zone
<br />
Quality / GMP | 17/10/2022 | By Sudeep Soparkar | 456
Unichem Labs bags ANDA approval from US FDA
Unichem's Ghaziabad plant will commercialise the product
Quality / GMP | 17/10/2022 | By Sudeep Soparkar | 771
EDQM conducts GMP inspection at Biocon's API site in Bengaluru
As per the filing, the inspection was held between September 12-14, 2022 and issued a list of deficiencies on October 5, 2022
Quality / GMP | 10/10/2022 | By Sudeep Soparkar | 386
Zydus Lifesciences-led arm bags US FDA approval for Brivaracetam tabs
The medicine would be produced at the group's formulation manufacturing plant in Ahmedabad Special Economic Zone
<br />
Quality / GMP | 06/10/2022 | By Sudeep Soparkar | 328
US FDA issues EIR to Suven Pharma's subsidiary
The pre-approval inspection was conducted between July 25 to July 29, 2022
Quality / GMP | 04/10/2022 | By Sudeep Soparkar | 672
Quality / GMP | 04/10/2022 | By Sudeep Soparkar | 364
Zydus Lifesciences bags US FDA approval for Sildenafil for Oral Suspension
The drug will be manufactured at the group’s formulation manufacturing facility at Baddi, Himachal Pradesh
Quality / GMP | 03/10/2022 | By Sudeep Soparkar | 378
Lupin gets EIR from US FDA for its Ankleshwar facility
The inspection of the facility was conducted from August 16-19, 2022
Quality / GMP | 03/10/2022 | By Sudeep Soparkar | 743
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy